Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: A randomized, double-blind, placebo-controlled study

Journal of the American College of Cardiology

Volumn 33, Issue 5, 1999, Pages 1227-1230

  Girolamo, Enrico Di ^a,c   Iorio, Cesare Di ^b   Sabatini, Panfilo ^b   Leonzio, Luigi ^b   Barbone, Carmela ^a   Barsotti, Antonio ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b CCU SS Annunziata Hospital   (Italy)

^c NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; INOTROPIC AGENT; MINERALOCORTICOID; PAROXETINE; PLACEBO; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HEAD TILTING; HUMAN; MALE; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SEROTONINERGIC SYSTEM; SEXUAL DYSFUNCTION; SYNCOPE;

ACUTE DISEASE; ADULT; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PAROXETINE; RECURRENCE; REFRACTORY PERIOD, ELECTROPHYSIOLOGICAL; SEROTONIN UPTAKE INHIBITORS; SYNCOPE, VASOVAGAL; TILT-TABLE TEST; TREATMENT OUTCOME;

EID: 0033117026     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00694-9     Document Type: Article

References (25)

1. Kenny RA, Bayliss J, Ingram A, Sutton R. Head-up tilt: a useful test for investigating unexplained syncope. Lancet 1986;1:1352-4.
2. Mark AL. The Betzold-Jarish reflex revisited: clinical implications of inhibitory reflexes originating in the heart. J Am Coll Cardiol 1983;1:90-102.
3. Van Lieshout JJ, Wieling W, Karemaker JM, Eckberg DL. The vasovagal response. Clin Sci 1991;81:575-86.
4. Abboud FM. Neurocardiogenic syncope. N Engl J Med 1993;328:1117-20.
5. Shalev Y, Gal R, Tchou PJ, et al. Echocardiographic demonstration of decreased left ventricular dimensions and vigorous myocardial contraction during syncope induced by head-up tilt. J Am Coll Cardiol 1991;18:746-53.
6. Rea R, Thames MD. Neural control mechanisms and vasovagal syncope. J Cardiovasc Electrophysiol 1993;4:587-95.
7. Kosinski D, Grubb BP, Temesy-Armos P. Pathophysiological aspects of neurocardiogenic syncope: current concepts and new perspectives. PACE 1995;18:716-24.
8. Chosy JJ, Graham DT. Catecholamines in vasovagal fainting. J Psychosom Res 1965;9:189-94.
9. Wallbridge DR, MacIntyre HE, Gray CE, Oldroyd KG, Rae AP, Cobbe SM. Role of endogenous opioids and catecholamines in vasovagal syncope. Eur Heart J 1996;17:1729-36.
10. Wallbridge DR, MacIntyre HE, Gray CE, Oldroyd KG, Rae AP, Cobbe SM. Increase in plasma beta-endorphines precedes vasodepressor syncope. Br Heart J 1994;71:446-8.
11. Sakuma I, Togashi H, Yoshioka M. N-methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimu-lates renal sympathetic nerve activity in vivo. A role for nitric oxide in the central regulation of sympathetic tone. Circ Res 1992;70:607-11.
12. Shen WK, Hammil SC, Munger TM, et al. Adenosine: potential modulator of vasovagal syncope. J Am Coll Cardiol 1996;28:146-54.
13. Elam RF, Bergmann F, Feuerstein G. The use of antiserotonergic agents for the treatment of acute hemorrhagic shock of cats. Eur J Pharmacol 1985;107:275-8.
14. Kosinski D, Grubb BP. Neurally mediated syncope with an update on indications and usefulness of head-upright tilt table testing and pharmacologic therapy. Curr Opin Cardiol 1994;9:53-64.
15. Grubb BP, Wolfe DA, Samoil D, Temesy-Armos P, Hahn H, Elliot L. Usefulness of fluoxetine hydrochloride for prevention of resistant upright tilt induced syncope. PACE 1993;16:458-64.
16. Grubb BP, Samoil D, Kosinski D, Kip K, Brewster P. Use of sertraline in the treatment of refractory neurocardiogenic syncope in children and adolescents. J Am Coll Cardiol 1994;24:490-4.
17. Grubb BP, Kosinski D. Preliminary observations on the use of venlafaxine hydrochloride in refractory orthostatic hypotension. J Serotonin Res 1996;6:89-94.
18. Fitzpatrick AP, Theodorakis G, Vardas P, Sutton R. Methodology of head-up tilt testing in patients with unexplained syncope. J Am Coll Cardiol 1991;17:125-30.
19. Raviele A, Menozzi C, Brignole M, et al. Value of head-up tilting test potentiated with sublingual nitroglycerin to assess the origin of unexplained syncope. Am J Cardiol 1995;76:267-72.
20. Sutton R, Petersen M, Brignole M, Raviele A, Menozzi C, Giani P. A proposed classification for tilt induced vasovagal syncope. Eur J Card Pacing Electrophysiol 1992;3:180-3.
21. Evans RG, Kapoor V, Ludbook J. A CNS serotonergic mechanism in acute central hypovolemia in conscious rabbits. J Cardiovasc Pharmacol 1986;19:1009-17.
22. Kosinski D, Grubb BP, Temesy-Armos P. The use of serotonin reuptake inhibitors in the treatment of neurally mediated cardiovascular disorders. J Serotonin Res 1994;1:85-90.
23. Grubb BP, Wolfe DA, Temesy-Armos P, Hahn H, Elliot L. Reproducibility of head upright tilt table test result in patients with syncope. PACE 1992;15:1477-81.
24. Morillo CA, Klein GJ, Gersh BJ. Can serial tilt testing be used to evaluate therapy in neurally mediated syncope? Am J Cardiol 1996;77:521-2.
25. Raviele A, Gasparini G, Di Pede F, Delise P, Bonso A, Piccolo E. Usefulness of head-up tilt test in evaluating patients with syncope of unknown origin and negative electrophysiologic study. Am J Cardiol 1990;65:1332-7.